Jonathan Shamash
Papers
2
Total Citations
39
H-Index
2
About
Dr. Jonathan Shamash is a leading urologic oncologist whose research centers on advanced surgical techniques for testicular cancer, particularly the refinement of robot-assisted retroperitoneal lymph node dissection (R-RPLND). His major contributions include pioneering a comparative analysis of peri-operative outcomes between robotic and open RPLND, demonstrating that robotic approaches can achieve comparable oncologic efficacy with reduced morbidity. His landmark 2021 study, with 35 citations, systematically evaluated 100 consecutive cases, establishing a critical evidence base for minimally invasive surgery in post-chemotherapy and primary settings. More recently, Dr. Shamash introduced the B-SAFE approach, a structured framework for patient selection that optimizes surgical candidacy and outcomes, published in 2025. This work has shaped clinical decision-making by defining parameters for safe, effective robotic intervention. With a growing citation impact, his research bridges the gap between innovation and practical application, offering trainees and surgeons a roadmap for adopting advanced techniques. Dr. Shamash’s commitment to rigorous comparative studies and standardized protocols underscores his role as a transformative figure in urologic oncology, advancing both surgical precision and patient recovery.
Research Focus
Key Achievements
Top Papers
- 1
- 2